Product Description
Modified Vaccinia Ankara (MVA) Smallpox Vaccine
Mechanisms of Action: Vaccine
Novel Mechanism: No
Modality: Vaccine
Route of Administration: Subcutaneous
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Company: Sanofi
Company Location: Europe
Company Founding Year: 1973
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Smallpox|Vaccinia
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT00079820 |
H-249-001 | P1 |
Completed |
Smallpox|Vaccinia |
2006-10-01 |
2019-03-21 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|